Comparison of Low-Dose Liraglutide Use Versus Other GLP-1 Receptor Agonists in Patients Without Type 2 Diabetes

Wittbrodt, ET; Eudicone, JM; Farahbakhshian, S; McAdam-Marx, C

Eudicone, JM (reprint author), AstraZeneca, Wilmington, DE 19803 USA.

AMERICAN JOURNAL OF MANAGED CARE, 2018; 24 (8): S156

Abstract

Objectives: The objective was to compare the use of low-dose liraglutide (LD-L) (Victoza) to the other glucagon-like peptide-1 receptor agonists (GLP-......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索